Infusion of heat-aggregated immunoglobulin G (HAG) into perfused livers from fed rats caused transient increases in hepatic glycogenolysis and portal-vein pressure, accompanied by a transient increase in hepatic glycogen phosphorylase a content. The hepatic responses to HAG were inhibited by indomethacin (2 ,UM). In contrast, HAG was without effect on phosphorylase a content and glucose output in isolated hepatocytes. HAG infusion caused a transient decrease in hepatic cyclic AMP. Lowering the extracellular Ca2+ concentration to 6 or 50 IaM attenuated markedly the glycogenolytic and haemodynamic responses to HAG; efflux of Ca2+ from the liver was not observed in response to HAG. Co-infusion of the specific platelet-activating-factor antagonist U-66985 (1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphoric acid 6'-trimethylammoniumhexyl ester) did not attenuate the glycogenolytic response to HAG. Infusion of prostaglandin E2 caused increases in glucose output, portal-vein pressure and the reduction state of the cytosolic NAD(H) redox couple similar to those seen with HAG. The present study suggests that the glycogenolytic activation after HAG infusion may be an indirect consequence of the haemodynamic response of the hepatic vasculature to stimulation of the reticuloendothelial cells of the liver.
INTRODUCTION
Soluble immune complexes are removed from the circulation by the reticuloendothelial system via an Fc-receptor-mediated process, with the liver comprising the major site of uptake [1] [2] [3] [4] . Infusion of heat-aggregated immunoglobulin G (HAG) into the isolated perfused rat liver leads to a transient stimulation of hepatic glycogenolysis and 02 consumption, with a concomitant synthesis and release of platelet-activating factor from the liver [5] . Synthetic platelet-activating factor (acetylglyceroether phosphocholine) has been demonstrated to activate hepatic glycogenolysis in the perfused rat liver [6, 7] and in the rat in vivo [8] . The purpose of the present study was to characterize further the process by which hepatic glycogenolysis is stimulated by HAG, and to elucidate the role of potential autacoid mediators in the stimulatory process.
EXPERIMENTAL Liver perfusion studies
Non-recirculating perfusion of livers in situ from male Sprague-Dawley rats (Harlan, Houston, TX, or Benton and Kingman, Vermont, CA, U.S.A.), weighing 160-200 g and fed on a standard laboratory chow ad libitum, was performed as described previously [9] at a constant flow rate of 35 ml/min. The perfusion medium was Krebs-Henseleit bicarbonate buffer, pH 7.4 [10] , saturated with 02/C02 (19: 1) and maintained at 37 'C. The CaCl2 concentration was 1.25 mm unless stated otherwise in the Figure legend. 02 consumption was monitored continuously with a Clark-type oxygen electrode placed in the perfusion circuit immediately after the liver. Portal-vein pressure, a measure of intrahepatic pressure [11] , was measured by using a Statham P23 pressure transducer in conjunction with an oscillographic recorder. Livers were perfused for 30 min before collection of samples to ensure removal of endogenous hormones, and to stabilize glucose output. Effluent perfusate samples were collected for 30 s intervals for assay of metabolites. Glucose was assayed by the method of Bergmeyer et al. [12] . Lactate and pyruvate were measured as described by Gutmann & Wahlefeld [13] and Passoneau & Lowry [14] respectively. Ca2+ was measured by atomic-absorption spectroscopy, with a Varian AA6 spectrometer. Metabolite values are presented as,tmol/h per g wet wt.
For measurement of cyclic AMP, phosphorylase a and adenine nucleotides, livers were freeze-clamped, stored and assayed as described previously [15] .
Hepatocyte studies
Preparation of hepatocytes, incubations and measurements of phosphorylase a and glucose output were described previously [16] . 
RESULTS
Conflicting results have appeared in the literature concerning the primary hepatic cell type involved in the uptake of soluble immune complexes from the circulation. Although several studies have indicated that Kupffer cells, the resident macrophage cells of the liver, are the predominant cell type involved [17, 18] , others have proposed that the parenchymal cell is the major target for soluble immune complexes [19, 20] . Hepatic responses to infused immune complexes could represent either a direct effect of the immune complex on the parenchymal cell, or an indirect effect exerted on the parenchymal cells via another cell type. Fig. 1 shows that HAG had no effect on the glycogen phosphorylase a content of isolated hepatic parenchymal cells (hepatocytes). In contrast, adrenaline increased the phosphorylase a content of hepatocytes by approx. 250%. A similar increase in hepatocyte glucose output was observed in response to adrenaline, but again HAG was without effect (results not shown).
In contrast with the lack of effect of HAG on hepatocyte phosphorylase a content, extracts of livers Effect of HAG and adrenaline on the glycogen phosphorylase a content of isolated rat hepatocytes Hepatocytes were isolated by collagenase perfusion of rat liver as described in the Experimental section. Isolated hepatocytes were incubated at 37°C in a shaking water bath, and samples removed at intervals for assay of phosphorylase a as described previously [16] perfused with HAG (10,ug/ml) contained significantly elevated phosphorylase a activity (Fig. 2) . Phosphorylase a activity was increased by approx. 60% (P < 0.001) 2 min after onset of HAG infusion, before returning to control values at 5 min. After 1 min phosphorylase a was increased by approx. 20%, but was not significantly different from control values. Indomethacin (2 uM), which inhibited the increase in glucose output in response to HAG [5] , also inhibited the increase in phosphorylase a content by approx. 40 %, with no effect on basal phosphorylase a activity. In a parallel series of experiments, indomethacin (2/M) decreased the maximal increase in glucose output in response to HAG (10 /g/ml) from 90+9 (n = 20) to 34+8,umol/h per g (n = 9; P < 0.001). Basal glucose output was 84 + 5 1mol/h per g (n = 20).
Measurement of hepatic cylic AMP in the freezeclamped liver tissue demonstrated that the HAG infusion did not lead to significant increase in cyclic AMP, but caused a small transient decrease in the cyclic nucleotide (Fig. 2) . In contrast, glucagon (10 nM) increased hepatic cyclic AMP approx. 50 glycogenolytic response to HAG Livers were perfused as described in the Experimental section with Ca2+-free buffer, and Ca2+ (1.25 mM) was infused in a syringe pump. Ca2+ infusion was stopped at 40 min; *, perfusion continued without Ca2+ (n = 10); Q, Ca2+ re-infused after 47 min (n = 3). Results are means from the numbers of experiments in parentheses. no effect on the effluent Ca2+ concentration (Fig. 3) Fig. 4 . Removal of added Ca2 , which lowered the perfusate Ca2+ concentration to approx. 7/tM (as measured by atomic-absorption spectroscopy) 5 min before infusion of HAG, markedly attenuated the glycogenolytic response to HAG, decreasing it from 90 + 9 (n = 20) to 30 + 5 ,umol/h per g (n = 10; P < 0.001); re-infusion of Ca2+ during HAG infusion led to a large increase in glucose output, 123+3,mol/h per g (n = 3), whereas in control experiments addition of Ca2+ to livers perfused without Ca2+ for the same length of time in the absence of HAG caused only a modest increase in glucose output, 27 + 41tmol/h per g (n = 12; P < 0.001). Addition of HAG to these control livers 5 min after addition of Ca2+ restored nearly completely the glycogenolytic response, to 73+ 16 ,umol/h per g (n = 9). Interestingly, in livers perfused with Ca2+-free media for 5 min before addition of HAG, addition of Ca2+ 8 min after cessation of HAG infusion still enhanced glucose output, e.g. to 75±11 Itmol/h per g (n=3; P<0.001 versus Ca2+ re-addition without HAG infusion), suggesting that a cellular process remains activated for several minutes.
Since infusion of synthetic platelet-activating factor into perfused livers has been demonstrated to cause hepatic vasoconstriction, which may be causally related to the glycogenolytic effect of this lipid mediator [15, 26] , the effect of HAG infusion on portal-vein pressure was determined. Fig. 5 shows that infusion of HAG led to a transient increase in portal-vein pressure, which was attenuated by co-infusion of indomethacin (2 /tM). The increase in portal-vein pressure was also attenuated at lower perfusate Ca2+ concentration (Table 1) .
In order to investigate the role of platelet-activating factor in the glycogenolytic response to HAG, the specific platelet-activating-factor antagonist U-66985 [27, 28] was employed. U-66985 (1 /tM) has been shown to inhibit hepatic responses to infused synthetic platelet- [28] . However, infusion of U-66985 into livers 5 min before co-infusion of HAG (10 ,ug/ml) did not affect the glycogenolytic response to HAG; the maximal increase in glucose output in the presence of U-66985 (1 /SM) was 81 + 17 ,umol/h per g (n = 7), and in a parallel control series without U-66985 the maximal increase was 80+14,umol/h per g (n = 7).
The inhibition of hepatic responses to HAG by indomethacin [5] suggested the possibility that a prostanoid mediator may be involved in the glycogenolytic and haemodynamic consequences of HAG infusion. Since hepatic Kupffer cells and other macrophage-type cells have been shown to release prostaglandins, including E2 and F, in response to phagocytic stimuli [29] [30] [31] , the effect of prostaglandin E2 infusion on hepatic parameters was investigated. The effects of prostaglandin E2 (10 ,uM) on hepatic glucose output, effluent lactate/pyruvate ratio and portal-vein pressure are shown in Fig. 6(a) ; it caused increases in these metabolic and haemodynamic indices similar to those observed in response to HAG. Total lactate + pyruvate output was also increased transiently by approx. 60%. Increases in all parameters were statistically significant (P < 0.01). Fig. 6(b) shows a partial dose/response for the stimulation of glycogenolysis and hepatic vasoconstriction by prostaglandin E2. Higher concentrations of prostaglandin E2 were not tested, owing to the prohibitive amount of material required.
Hepatic responses to prostaglandin E2 also were markedly attenuated at 7 /sM perfusate calcium; the glycogenolytic response to prostaglandin E2 (10 ,UM) was decreased from 55 ± 8 (n = 6) to 12 ,umol/h per g (n = 2) and the change in the portal-vein pressure was similarly attenuated (results not shown).
DISCUSSION
The present study has demonstrated that the increases in glucose output and glycogen phosphorylase a content of perfused rat liver in response to HAG are mediated neither by a cyclic-AMP-dependent mechanism, analogous to glucagon and ,-adrenergic agonists, nor by release of intracellular Ca2+, analogous to stimulation by a-adrenergic agonists, vasopressin and adenine nucleotides. However, Ca2+ clearly is important for full expression of the hepatic responses to HAG. Since removal of Ca2+ for only 5 min markedly attenuated hepatic responses to HAG, it is likely that extracellular Ca2+ is important, and that inhibition of HAG-mediated glucose output and the elevated portal-vein pressure by Ca2+ removal do not reflect depletion of intracellular Although several studies have demonstrated hyperglycaemic effects ofprostaglandins in vivo [32] [33] [34] , studies in vitro have furnished apparently conflicting results. Whereas some studies have demonstrated glycogenolytic responses to prostaglandins in isolated hepatic systems [34] [35] [36] , others have shown no effect [37] [38] [39] [40] or inhibition [41] of hepatic glycogenolysis by E-series prostaglandins, leading to the suggestion [40] that the hyperglycaemia observed in response to prostaglandins in vivo may be secondary to changes in hormonal status [42] [43] [44] . It is clear from the present study that prostaglandin E2 has glycogenolytic effects in the perfused rat liver. The haemodynamic changes observed in response to both prostaglandin E2 and HAG, and the concomitant transient increase in the effluent lactate/pyruvate ratio, indicative of a more reduced state for the cytosolic NADH/NAD+ couple [45] , are consistent with transient hypoxia caused by changes in the hepatic microcirculation. Hypoxia has been demonstrated to stimulate hepatic glycogenolysis rapidly, possibly by increases in AMP and ADP leading to activation of glycogen phosphorylase [46, 47] . Measurement of adenine nucleotides in freeze-clamped liver extracts did not show any significant differences between control and HAG-treated livers (results not shown); however, in view of the complex microcirculation of the liver [48] [49] [50] , it is likely that rearrangements in hepatic flow may cause local hypoxia without causing measurable changes in global tissue adenine nucleotide content. An indirect mechanism for prostaglandin E2 stimulation of glycogenolysis would explain the lack of effect of prostaglandin E2 in isolated parenchymal cells [40] .
The requirement for extracellular Ca2+ for full expression of the glycogenolytic response to HAG may be related to the demonstration that Ca2+ influx is an initial event in responses of Kupffer cells to phagocytic stimuli [31, 51] ; superoxide release by primary cultures of Kupffer cells in response to zymosan was inhibited in the absence of Ca2+ [51] , and addition of the Ca2+ ionophore A23187 to Kupffer-cell cultures mimicked the effect of zymosan in stimulating prostaglandin release [31] . An alternative or additional role for Ca2+ may lie in a requirement of Ca2+ in the vasoconstrictive response. If the suggestion that prostaglandin E2 may be involved in mediating the hepatic responses to HAG is correct, the inhibition of hepatic responses to prostaglandin E2 by Ca2+ removal would be consistent with such a role for Ca2+. Although the prostaglandin concentration required to stimulate hepatic glycogenolysis is rather high, it should be noted that the liver removes from the circulation and metabolizes prostaglandins rapidly, the perfused liver clearing 90% of infused prostaglandin in a single pass [52] , and thus there will be a steep prostaglandin concentration gradient across the liver. Additionally, treatment of isolated macrophages with immune complexes can elevate the prostaglandin concentration in the incubation medium to micromolar values [30] , demonstrating that high local concentrations of prostaglandin in the perfused liver are feasible.
In summary, the present study suggests that HAG stimulates glycogenolysis in the perfused liver by an indirect mechanism involving mediator production and hepatic vasoconstriction. Moreover, a potential role for prostaglandin E2 in mediating these hepatic responses to HAG infusion is suggested.
